Evidence map›Paper›PMID 42838940›Full record

ArticleNature communications2026

Whole genome sequencing of 1427 Mexican individuals from the oriGen cohort.

Israel Aguilar-Ordoñez, Eugenio Guzman-Cerezo, David Torres-Treviño, Alvaro Colin-Oviedo, Rocio Ortiz-Lopez, Elena-Cristina Gonzalez-Castillo, Nestor Rubio-Infante, Jose Ramirez-Vega, Rocio-Alejandra Chavez-Santoscoy, Cuitlahuac Ruiz-Matus and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Israel Aguilar-OrdoñezTecnologico de Monterrey, oriGen Project, Monterrey, México.
Eugenio Guzman-CerezoTecnologico de Monterrey, oriGen Project, Monterrey, México.
David Torres-TreviñoTecnologico de Monterrey, oriGen Project, Monterrey, México.ORCID 0009-0006-6859-0459
Alvaro Colin-OviedoTecnologico de Monterrey, oriGen Project, Monterrey, México.
Rocio Ortiz-LopezTecnologico de Monterrey, oriGen Project, Monterrey, México.
Elena-Cristina Gonzalez-CastilloTecnologico de Monterrey, oriGen Project, Monterrey, México.
Nestor Rubio-InfanteTecnologico de Monterrey, oriGen Project, Monterrey, México.
Jose Ramirez-VegaTecnologico de Monterrey, oriGen Project, Monterrey, México.
Rocio-Alejandra Chavez-SantoscoyTecnologico de Monterrey, oriGen Project, Monterrey, México.ORCID 0000-0002-4551-1862
Cuitlahuac Ruiz-MatusTecnologico de Monterrey, oriGen Project, Monterrey, México.
Martin De-La-CruzTecnologico de Monterrey, TecMed Center, Monterrey, México.
Gerado Garcia-RivasTecnologico de Monterrey, Institute for Obesity Research, Monterrey, México.
Servando CardonaTecnologico de Monterrey, School of Medicine and Health Sciences, Monterrey, México.
Pablo Kuri-MoralesTecnologico de Monterrey, oriGen Project, Monterrey, México.
Guillermo Torre-AmioneTecnologico de Monterrey, oriGen Project, Monterrey, México.
Víctor TreviñoTecnologico de Monterrey, oriGen Project, Monterrey, México. vtrevino@tec.mx.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Latin American populations remain underrepresented in genomic research. To help address this, we present an analysis of high-coverage whole-genome data from 1481 volunteers recruited as part of the oriGen Project. We identify over 47.2 million SNVs and 8.1 million short indels, including nearly 3 million non-singleton short variants absent from dbSNP and the Mexico City Prospective Study. Admixture analysis indicates that a Mexican training dataset is needed to more accurately estimate ancestry compositions by genetic similarity. Analysis of copy number variation associated with MX-AMR highlights several loci, including LCE1D and RHD. Interestingly, while 3.1% of participants carry homozygous deletions in the RHD gene, which determines the Rh blood group, this frequency dropped to 0.6% among individuals with high MX-AMR. Since the RHD deletion is rare in East Asians, and the Rh-negative phenotype is rare in Indigenous American populations, our results support the hypothesis that the Rh-negative blood group increased in frequency during the Spanish conquest rather than by genetic drift. We also find that 10% of volunteers are heterozygotes for the 22-42128945-C-T Loss of Function variant in CYP2D6, an enzyme involved in metabolizing painkillers, and tamoxifen. This work helps address the underrepresentation of Mexican populations in genomic research.

Indexed as

Genome, HumanWhole Genome SequencingCohort StudiesCytochrome P-450 CYP2D6DNA Copy Number VariationsFemaleHumansINDEL MutationMexicoPolymorphism, Single NucleotideRh-Hr Blood-Group SystemCytochrome P-450 CYP2D6Rh-Hr Blood-Group System

Identifiers

PMID42838940
PMCPMC13642253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.